Best Continuous Glucose Monitors for Non-Diabetics (2026)

TL;DR

Top pick: Stelo by Dexcom (~$89-99/mo) — most accurate OTC sensor (8.3% MARD), 15-day wear, iOS + Android, Apple Health integration.
Best value: Lingo by Abbott (~$49/sensor) — cheapest entry, app-based coaching, no subscription required.
Best coached program: Nutrisense (~$149/mo, 6-mo plan) — Stelo sensors + 1:1 registered dietitian, HSA/FSA eligible.

The OTC CGM market split into standalone sensors (Stelo, Lingo) and subscription programs (Levels, Signos, Nutrisense) by 2026. [src2, src3]

The OTC CGM market opened in March 2024 when the FDA cleared Stelo by Dexcom as the first non-prescription glucose biosensor for adults not on insulin, followed by Abbott's Lingo in August 2024. By 2026 the category has split into two layers: standalone OTC sensors (Stelo, Lingo) sold directly via Amazon and pharmacy, and subscription "metabolic health programs" (Levels, Signos, Nutrisense) that bundle a Stelo sensor with their own app, AI insights, or human coaching. Signos became the first FDA-cleared OTC CGM-AI system for weight management in March 2025, raising the regulatory floor for wellness claims. [src1, src2, src5]

Independent testing places Stelo's mean absolute relative difference (MARD) at ~8.3% versus lab YSI, slightly better than Lingo at ~9.3%; Stelo also lasts 15 days to Lingo's 14 and supports Android natively and Apple Health, Oura, and Nutrisense integration. Lingo wins on coaching: its app translates spikes into real-time food-and-activity guidance using a daily "Lingo Count," the closest thing to a built-in dietitian without paying for one. Subscription programs charge $24-$199/month on top of the sensor cost in exchange for richer analytics, food databases, RD chat, or AI-driven exercise recommendations. [src2, src3, src8]

The category remains volatile: Zoe dropped its CGM from US membership in early 2026 to focus on microbiome-only testing, and several non-invasive smartwatch glucose claims have been challenged by the FDA. For non-diabetic users the OTC sensors are screening and behavior-change tools — not medical devices for dosing decisions — and they should never replace clinical care for anyone with type 1 diabetes or insulin-dependent type 2. [src1, src4, src5]

Best Overall: Stelo by Dexcom (~$89-99/mo) — Check price

Stelo took the consensus top spot across CNN Underscored, Athletech, and Plotline Health for 2026. MARD of ~8.3% (93% of readings within 20/20% YSI), 15-day wear plus a 12-hour grace period, waterproof to 8 ft, and AI-driven "Spike Insights" inside the Stelo app. Works on iOS and Android, integrates with Apple Health and Oura, and Stelo is currently the only OTC CGM that supports direct provider data sharing. Subscription drops cost to $89/mo; pay-as-you-go is $99 for a 2-pack on Amazon. [src1, src2, src6]

Best Value: Lingo by Abbott (~$49/sensor) — Check price

Lingo is the cheapest legitimate way into CGM — $49 buys 14 days of glucose data with no subscription required. The app's "Lingo Count" coaching turns spikes into actionable food and movement guidance, which CNN Underscored called the most beginner-friendly experience of any OTC CGM. MARD ~9.3%, 14-day wear, 60-minute warm-up. Best when you want a one-month experiment, not a year-long commitment. [src2, src3, src8]

Best for Coaching App: Lingo by Abbott — Check price

The Lingo app's coaching layer is materially more directive than Stelo's: it scores meals in real time, sets a daily Lingo Count target, and nudges you toward actions ("walk for 10 minutes to flatten this curve"). For users who want behavior change without paying for a human coach, this is the highest-output app in the OTC tier. [src8]

Best Dietitian-Led Program: Nutrisense (~$149/mo on 6-mo plan) — Check price

Nutrisense uses Stelo sensors but layers a 1:1 registered dietitian on every plan — no other consumer CGM service includes RD coaching as standard. Plans are HSA/FSA eligible and 95% of users pay $0 for the dietitian video calls (insurance-covered). Bring-your-own-sensor app-only tier is $39/mo for users who already buy Stelo on Amazon. [src4]

Best Metabolic Dashboard: Levels Health ($24-$167/mo + Stelo) — Check price

Levels' Classic tier is the cheapest "program" entry at $24/mo (or $288/yr) plus ~$89/mo for Stelo sensors. The app's metabolic score, 1-10 zone system, AI photo food logging, and ability to overlay glucose with workouts and sleep make it the most data-rich consumer experience. Higher tiers (Core $499/yr, Complete $1,999/yr) add Quest blood-panel labs and nutritionist consults. [src4, src7]

Best for Weight Management: Signos (~$129-$199/mo) — Check price

Signos became the first FDA-cleared OTC glucose-monitoring system specifically indicated for weight management in March 2025. Its AI app uses the Stelo sensor and recommends timed exercise to clear glucose spikes, with research showing ~87% of users change food choices based on glucose feedback. Especially relevant for users on GLP-1s or post-bariatric surgery who want to monitor metabolic response. Pricing tiers: $199 (1-mo), $139 (3-mo), $129 (6-mo); $75/mo maintenance for existing members. [src5]

Best Clinical-Grade for Prediabetics: Dexcom G7 (Rx) (~$178+/mo) — Check price

If a user has confirmed prediabetes, a metabolic syndrome diagnosis, or wants alarms (high/low alerts that Stelo and Lingo don't offer), the Dexcom G7 is the prescription-only step up. Direct Apple Watch streaming, dosing-grade accuracy, and broad ecosystem (Tidepool, Loop). Amazon Pharmacy lists 3-sensor packs from $177-$388 without insurance. [src1]

Best Rx Alternative: FreeStyle Libre 3 Plus — Check price

Libre 3 Plus extends the OTC Libre platform to 15-day clinical-grade wear with alarms. Most affordable prescription CGM after insurance, often $75-$140/mo at retail pharmacies. For users transitioning from Lingo who want clinical accuracy, this is the natural upgrade. [src1]

Head-to-Head Comparisons

Stelo by Dexcom vs Lingo by Abbott

Stelo wins on accuracy (8.3% vs 9.3% MARD), wear time (15 vs 14 days), Android support at launch, and integrations (Apple Health, Oura, provider data sharing). Lingo wins on price ($49 vs $89-99) and coaching app quality. CNN Underscored's two-week head-to-head test concluded Stelo for data depth, Lingo for behavior change. [src2, src3]

Pick Stelo if: you want the most accurate OTC sensor, plan to integrate with Apple Health / Oura, or share data with a doctor.
Pick Lingo if: you want the cheapest first experiment, value an app coach, or commit only to one month at a time.

Stelo by Dexcom vs Levels Health

Both use the Stelo sensor — Levels just rents you a richer software layer. Stelo standalone is $89/mo for sensors + a basic app; Levels Classic adds metabolic scores, AI food photo logging, and historical trend search for $24/mo on top of the sensor. Power users prefer Levels' analytics; minimalists prefer Stelo's stock app. [src4, src7]

Pick Stelo standalone if: you trust the Dexcom app and want to keep cost under $100/mo.
Pick Levels if: you want metabolic scores, food-database analytics, and the option to add lab panels later.

Lingo by Abbott vs Signos

Lingo and Signos both target behavior change but at different price points. Lingo is $49 for one sensor, AI app coaching, no subscription lock-in. Signos is $129-$199/mo (sensors included), FDA-cleared specifically for weight loss, with workout-timing recommendations. [src5, src8]

Pick Lingo if: budget < $80/mo, comfortable self-directing with app coaching.
Pick Signos if: weight loss is the primary goal, especially on a GLP-1, or you want the FDA-cleared weight-management indication.

Nutrisense vs Levels Health

Nutrisense' differentiator is human RD coaching included in every tier; Levels' is the analytics dashboard plus optional lab panels. Nutrisense plans run $149-$215/mo (sensors included); Levels Classic is $24/mo + $89/mo sensors (~$113/mo combined). [src4]

Pick Nutrisense if: you want a dietitian to interpret your data weekly.
Pick Levels if: you trust software over coaching and want detailed metabolic analytics.

Decision Logic

If budget is < $60/mo

→ Lingo by Abbott ($49 single sensor). Cheapest entry, no subscription. Skip Stelo unless you commit to subscription pricing. [src2, src3]

If primary goal is weight loss or GLP-1 support

→ Signos ($129-$199/mo). Only FDA-cleared OTC CGM-AI specifically indicated for weight management; AI recommends timed exercise to clear spikes. [src5]

If user wants the most accurate OTC sensor + Apple Health / Oura integration

→ Stelo by Dexcom ($89-99/mo). Lowest MARD, longest wear, best integrations. [src1, src6]

If user wants 1:1 dietitian coaching on every plan

→ Nutrisense ($149/mo on 6-mo plan). HSA/FSA eligible; the only program with RD support standard. [src4]

If user has prediabetes diagnosis or wants high/low alarms

→ Dexcom G7 with prescription (~$178+/mo). OTC Stelo and Lingo do NOT offer alarms — required for borderline-clinical use cases. [src1]

If user is iOS-only and wants the slickest coaching app

→ Lingo by Abbott. App was iOS-first; in-app Lingo Count coaching is materially more directive than Stelo's app. [src8]

Default recommendation (unknown requirements, non-diabetic adult, $90-$130 budget)

→ Stelo by Dexcom ($89-99/mo subscription). Highest accuracy, broadest compatibility, no platform lock-in. Safest pick when goal is unclear. [src2, src6]

• Two-layer market is settling: standalone OTC sensors (Stelo, Lingo) for ~$50-100/mo and subscription programs (Levels, Signos, Nutrisense) for $130-$200/mo that bundle a Stelo sensor with software or coaching. Expect more "bring-your-own-sensor" tiers as Stelo Amazon distribution matures. [src4, src7]
• FDA cleared first weight-management CGM-AI: Signos received clearance in March 2025 (launched Aug 2025) for weight management — opens the door for prescription-grade outcome claims at OTC pricing. [src5]
• Stelo dominates the sensor layer: Levels, Signos, and Nutrisense all now use Stelo (or offer it as the default). Abbott's Lingo runs on its own ecosystem and remains the standalone-sensor alternative. [src4, src7]
• Apple Health, Oura, Whoop integrations standardizing: Stelo natively syncs with Apple Health, Oura, and Nutrisense; expect Whoop and Garmin direct integrations by H2 2026. [src6]
• Zoe US dropped CGM in early 2026: Pivoted to microbiome-only testing, cutting CGM and blood-fat tests from membership. The CGM-as-bundled-feature model is consolidating. [src4]
• MARD compressing toward 8%: Both Stelo (8.3%) and Lingo (9.3%) now sit close to clinical-grade Dexcom G7 (~8%) — accuracy gap between OTC and Rx is narrowing. [src3]
• Non-invasive watch/ring claims still unproven: As of mid-2026 no smartwatch or ring has FDA clearance for glucose measurement; the FDA has issued explicit warnings about products claiming this. [src5]

• OTC CGMs are NOT for type 1 or insulin-dependent type 2 diabetics. They lack alarms and are FDA-cleared only for adults 18+ not taking insulin. Anyone managing insulin needs a prescription clinical CGM (Dexcom G7, FreeStyle Libre 3 Plus).
• Sensor lag is real. Interstitial-fluid readings trail capillary blood by 5-15 minutes during rapid glucose changes (post-meal spikes, intense exercise). Cross-check with a fingerstick if a reading drives a major decision.
• Prices vary by channel and promotion. Stelo and Lingo on Amazon often track 5-15% above direct subscription pricing; programs (Levels, Signos, Nutrisense) discount heavily on multi-month plans.
• Insurance generally does not cover non-diabetic CGM use. HSA/FSA eligibility varies — Lingo is HSA-eligible, Nutrisense and Signos market HSA/FSA acceptance, but standalone Stelo is HSA-eligible only with a Letter of Medical Necessity.
• Manufacturer "accuracy" claims should be cross-checked. Independent MARD figures (~8-9%) are more reliable than marketing percentages, which often quote best-case lab conditions.
• Sensor failure / early loss is common. A Dexcom-funded study found only 77.9% of Stelo sensors lasted the full 15 days. Budget for ~10-20% sensor loss when calculating cost-per-day.
• This card is informational, not medical advice. Consult a qualified clinician before using a CGM to make health decisions, especially if you take medications that affect blood glucose.